Recent advances regarding the biology of adipose tissue have demonstrated that white adipose tissue (WAT) plays a central role in the regulation of energy balance and acts as a secretory/endocrine organ that mediates numerous physiological and pathological processes. Dysregulation of WAT mass causes obesity or lipoatrophy, two disorders associated with life-threatening pathologies, including cardiovascular diseases and diabetes. Alterations in WAT mass result from changes in adipocyte size and/or number. Change in adipocyte number is achieved through a complex interplay between proliferation and differentiation of preadipocytes. Adipocyte differentiation or adipogenesis is a highly controlled process that has been extensively studied for the last 25 years. In vitro preadipocyte culture systems that recapitulate most of the critical aspects of fat cell formation in vivo have allowed a meticulous dissection of the cellular and molecular events involved in the adipogenesis process. The adipogenic transcription factors peroxisome proliferator-activated receptor-γ and CCAAT/enhancer binding protein-α play a key role in the complex transcriptional cascade that occurs during adipogenesis. Hormonal and nutritional signaling affects adipocyte differentiation in a positive or negative manner, and components involved in cell-cell or cell-matrix interactions are also pivotal in regulating the differentiation process. This knowledge provides a basis for understanding the physiological and pathophysiological mechanisms that underlie adipose tissue formation and for the development of novel and sound therapeutic approaches to treat obesity and its related diseases.
HeinePA, TaylorJA, IwamotoGA, LubahnDB, CookePS. Increased adipose tissue in male and female estrogen receptor-α knockout mice. Proc Natl Acad Sci U S A97:12729–12734, 2000.
7.
Lea-CurrieYR, WenP, McIntoshMK. Dehydroepiandrosterone-sulfate (DHEAS) reduces adipocyte hyperplasia associated with feeding rats a high-fat diet. Int J Obes Relat Metab Disord21:1058–1064, 1997.
8.
OkunoA, TamemotoH, TobeK, UekiK, MoriY, IwamotoK, UmesonoK, AkanumaY, FujiwaraT, HorikoshiH, YazakiY, KadowakiT.Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest101:1354–1361, 1998.
9.
ShepherdPR, GnudiL, TozzoE, YangH, LeachF, KahnBB. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem268:22243–22246, 1993.
10.
HalvorsenYD, BondA, SenA, FranklinDM, Lea-CurrieYR, SujkowskiD, EllisPN, WilkisonWO, GimbleJM. Thiazolidinediones and glucocorticoids synergistically induce differentiation of human adipose tissue stromal cells: biochemical, cellular, and molecular analysis. Metabolism50:407–413, 2001.
11.
SenA, Lea-CurrieYR, SujkowskaD, FranklinDM, WilkisonWO, HalvorsenYD, GimbleJM. Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J Cell Biochem81:312–319, 2001.
12.
WabitschM, BrennerRE, MelznerI, BraunM, MollerP, HeinzeE, DebatinKM, HaunerH.Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord25:8–15, 2001.
13.
ZukPA, ZhuM, MizunoH, HuangJ, FutrellJW, KatzAJ, BenhaimP, LorenzHP, HedrickMH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng7:211–228, 2001.
14.
RangwalaSM, LazarMA. Transcriptional control of adipogenesis. Annu Rev Nutr20:535–559, 2000.
15.
RosenED, SpiegelmanBM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol16:145–171, 2000.
16.
MacDougaldOA, LaneMD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem64:345–373, 1995.
17.
EntenmannG, HaunerH.Relationship between replication and differentiation in cultured human adipocyte precursor cells. Am J Physiol270:C1011–C1016, 1996.
18.
QiuZ, WeiY, ChenN, JiangM, WuJ, LiaoK.DNA synthesis and mitotic clonal expansion is not a required step for 3T3-L1 preadipocytes differentiation into adipocytes. J Biol Chem276:11988–11995, 2001.
ZhaoL, GregoireF, Sook SulH.Transient induction of ENC-1, a Kelch-related actin-binding protein, is required for adipocyte differentiation. J Biol Chem275:16845–16850, 2000.
21.
BooneC, MourotJ, GregoireF, RemacleC.The adipose conversion process: regulation by extracellular and intracellular factors. Reprod Nutr Dev40:325–358, 2000.
22.
NtambiJM, Young-CheulK.Adipocyte differentiation and gene expression. J Nutr130:3122S–3126S, 2000.
23.
GuoX, LiaoK.Analysis of gene expression profile during 3T3-L1 preadipocyte differentiation. Gene251:45–53, 2000.
24.
OsborneTF. Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J Biol Chem275:32379–32382, 2000.
25.
HammJK, ParkBH, FarmerSR. A role for C/EBPβ in regulating peroxisome proliferator-activated receptor-γ activity during adipogenesis in 3T3-L1 preadipocytes. J Biol Chem276:18464–18471, 2001.
26.
AmriEZ, BoninoF, AilhaudG, AbumradNA, GrimaldiPA. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes: homology to peroxisome proliferator-activated receptors. J Biol Chem270:2367–2371, 1995.
27.
BrunRP, TontonozP, FormanBM, EllisR, ChenJ, EvansRM, SpiegelmanBM. Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev10:974–984, 1996.
28.
BastieC, HolstD, GaillardD, Jehl-PietriC, GrimaldiPA. Expression of peroxisome proliferator-activated receptor PPARδ promotes induction of PPARγ and adipocyte differentiation in 3T3C2 fibroblasts. J Biol Chem274:21920–21925, 1999.
SteppanCM, BrownEJ, WrightCM, BhatS, BanerjeeRR, DaiCY, EndersGH, SilbergDG, WenX, WuGD, LazarMA. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A98:502–506, 2001.
42.
HuE, LiangP, SpiegelmanBM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem271:10697–10703, 1996.
43.
SchererPE, WilliamsS, FoglianoM, BaldiniG, LodishHF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem270:26746–26749, 1995.
44.
AritaY, KiharaS, OuchiN, TakahashiM, MaedaK, MiyagawaJ, HottaK, ShimomuraI, NakamuraT, MiyaokaK, KuriyamaH, NishidaM, YamashitaS, OkuboK, MatsubaraK, MuraguchiM, OhmotoY, FunahashiT, MatsuzawaY.Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun257:79–83, 1999.
45.
FruebisJ, TsaoTS, JavorschiS, Ebbets-ReedD, EricksonMR, YenFT, BihainBE, LodishHF. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A98:2005–2010, 2001.
46.
Tartare-DeckertS, ChaveyC, MonthouelMN, GautierN, Van ObberghenE.The matricellular protein SPARC/osteonectin as a newly identified factor upregulated in obesity. J Biol Chem276:22231–22237, 2001.
47.
BrekkenRA, SageEH. SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol19:815–827, 2001.
48.
Juhan-VagueI, AlessiMC, MorangePE. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Ann Med32(Suppl 1):78–84, 2000.
49.
KerstenS, MandardS, TanNS, EscherP, MetzgerD, ChambonP, GonzalezFJ, DesvergneB, WahliW.Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem275:28488–28493, 2000.
50.
YoonJC, ChickeringTW, RosenED, DussaultB, QinY, SoukasA, FriedmanJM, HolmesWE, SpiegelmanBM. Peroxisome proliferator-activated receptor-δ target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol Cell Biol20:5343–5349, 2000.
